3,3'-methyliminobis(n-methylpropylamine) profile

Description

3,3'-methyliminobis(N-methylpropylamine): neurotoxic triamine; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	67161
SCHEMBL ID	1231390
MeSH ID	M0103912

Synonyms (43)

Synonym
LS-13732
1,3-propanediamine, n,n'-dimethyl-n-[3-(methylamino)propyl]-
n,n',n-trimethyldiitrimethylenetriamine
nsc-166322
1, n,n'-dimethyl-n-[3-(methylamino)propyl]-
3,3'-methyliminobis(n-methylpropylamine)
nsc166322
123-70-6
n,n'-dimethylmethyliminobis(dipropylamine)
3,3'-bis(methylamino)-n-methyldipropylamine
dipropylamine,3'-bis(methylamino)-
n,n-bis[3-(methylamino)propyl]methylamine
n,n'-dimethyl-n'-[3-(methylamino)propyl]propane-1,3-diamine
1,3-propanediamine, n1,n3-dimethyl-n1-(3-(methylamino)propyl)-
dipropylamine, n-methyl-3,3'-bis(methylamino)-
1,3-propanediamine, n,n'-dimethyl-n-(3-(methylamino)propyl)-
3,3'-bis(methylamino)-n-methyl-dipropylamine
einecs 204-645-0
methylbis(3-methylaminopropyl)amine
3,3'-methylimino-bis-(n-methylpropylamine)
nsc 166322
n1,n3-dimethyl-n1-(3-(methylamino)propyl)propane-1,3-diamine ,
AKOS015918218
n,n',n''-trimethyldiitrimethylenetriamine
PQYGBJHVVYREGU-UHFFFAOYSA-N
DTXSID8059558
SCHEMBL1231390
J-004975
n,n-bis[3-(methylamino)propyl]methylamine, 98%
GEO-04122
n1,n3-dimethyl-n1-[3-(methylamino)propyl]-1,3-propanediamine
RU2C4AX4WA
n,n-bis[3-(methylamino)-propyl]methylamine
1,3-propanediamine, n1,n3-dimethyl-n1-[3-(methylamino)propyl]-
FT-0706750
mfcd00014857
3,3'-methylimino-bis-(n-methylpropyl-amine)
D97800
n-methyl-3,3'-bis(methylamino)dipropylamine
STARBLD0000245
CS-0456849
n1,n3-dimethyl-n1-[3-(methylamino)propyl]propane-1,3-diamine
SY358373

Research

Studies (7)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	6 (85.71)	18.7374
1990's	1 (14.29)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	1 (14.29%)	4.05%
Observational	0 (0.00%)	0.25%
Other	6 (85.71%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Description	Relationhip Strength	Studies	Classes
gold	[no description available]	medium	2	copper group element atom; elemental gold
bipiperidyl mustard	[no description available]	medium	1
piperidines	[no description available]	medium	1

Condition	Relationship Strength	Studies
Acid beta-Glucosidase Deficiency	low	1
Acid beta-Glucosidase Deficiency Disease	low	1
Acute Neuronopathic Gaucher Disease	low	1
Allergic Encephalomyelitis	low	2
Allergic Encephalomyelitis, Experimental	low	2
Alloxan Diabetes	low	1
Astrocytoma, Grade IV	low	1
Autoimmune Encephalomyelitis, Experimental	low	2
Autoimmune Experimental Encephalomyelitis	low	2
Benign Neoplasms, Brain	low	1
Brain Cancer	low	1
Brain Diseases	low	2
Brain Disorders	low	2
Brain Edema	low	1
Brain Metastases	low	1
Brain Neoplasm, Primary	low	1
Brain Neoplasms	low	1
Brain Neoplasms, Benign	low	1
Brain Neoplasms, Malignant	low	1
Brain Neoplasms, Malignant, Primary	low	1
Brain Neoplasms, Primary Malignant	low	1
Brain Swelling	low	1
Brain Tumor, Primary	low	1
Brain Tumor, Recurrent	low	1
Brain Tumors	low	1
Cancer of Brain	low	1
Cancer of the Brain	low	1
Central Nervous System Disorders, Intracranial	low	2
Central Nervous System Intracranial Disorders	low	2
Cerebral Edema	low	1
Cerebral Edema, Cytotoxic	low	1
Cerebral Edema, Vasogenic	low	1
Cerebroside Lipidosis Syndrome	low	1
Chronic Gaucher Disease	low	1
CNS Disorders, Intracranial	low	2
Cytotoxic Brain Edema	low	1
Cytotoxic Cerebral Edema	low	1
Diabetes Mellitus, Experimental	low	1
Encephalomyelitis, Allergic	low	2
Encephalomyelitis, Autoimmune, Experimental	low	2
Encephalomyelitis, Experimental Autoimmune	low	2
Encephalon Diseases	low	2
Encephalopathy	low	2
Experimental Allergic Encephalomyelitis	low	2
Experimental Autoimmune Encephalomyelitis	low	2
Experimental Diabetes Mellitus	low	1
Froehlich's Syndrome	low	1
Gaucher Disease	low	1
Gaucher Disease Type 1	low	1
Gaucher Disease Type 2	low	1
Gaucher Disease Type 3	low	1
Gaucher Disease, Acute Neuronopathic	low	1
Gaucher Disease, Acute Neuronopathic Type	low	1
Gaucher Disease, Chronic	low	1
Gaucher Disease, Chronic Neuronopathic Type	low	1
Gaucher Disease, Infantile	low	1
Gaucher Disease, Infantile Cerebral	low	1
Gaucher Disease, Juvenile	low	1
Gaucher Disease, Juvenile and Adult, Cerebral	low	1
Gaucher Disease, Neuronopathic	low	1
Gaucher Disease, Non-Neuronopathic Form	low	1
Gaucher Disease, Noncerebral Juvenile	low	1
Gaucher Disease, Subacute Neuronopathic Form	low	1
Gaucher Disease, Subacute Neuronopathic Type	low	1
Gaucher Disease, Type 1	low	1
Gaucher Disease, Type 2	low	1
Gaucher Disease, Type 3	low	1
Gaucher Disease, Type I	low	1
Gaucher Disease, Type II	low	1
Gaucher Disease, Type III	low	1
Gaucher Splenomegaly	low	1
Gaucher Syndrome	low	1
Gaucher's Disease	low	1
Gauchers Disease	low	1
GBA Deficiency	low	1
Giant Cell Glioblastoma	low	1
Glioblastoma	low	1
Glioblastoma Multiforme	low	1
Glucocerebrosidase Deficiency	low	1
Glucocerebrosidase Deficiency Disease	low	1
Glucocerebrosidosis	low	1
Glucosyl Cerebroside Lipidosis	low	1
Glucosylceramidase Deficiency	low	1
Glucosylceramide Beta-Glucosidase Deficiency	low	1
Glucosylceramide Beta-Glucosidase Deficiency Disease	low	1
Glucosylceramide Lipidosis	low	1
Hypothalamic Diseases	low	1
Hypothalamic Dysfunction Syndromes	low	1
Hypothalamic Dysinhibition Syndrome	low	1
Hypothalamic Overactivity Syndrome	low	1
Hypothalamic Pseudopuberty	low	1
Hypothalamic-Adenohypophyseal Disorders	low	1
Hypothalamic-Neurohypophyseal Disorders	low	1
Infantile Gaucher Disease	low	1
Intracranial Central Nervous System Disorders	low	2
Intracranial CNS Disorders	low	2
Intracranial Edema	low	1
Intracranial Neoplasms	low	1
Kerasin Histiocytosis	low	1
Kerasin Lipoidosis	low	1
Kerasin thesaurismosis	low	1
Lipoid Histiocytosis (Kerasin Type)	low	1
Malignant Neoplasms, Brain	low	1
Malignant Primary Brain Neoplasms	low	1
Malignant Primary Brain Tumors	low	1
Necrosis	low	2
Neoplasms, Brain	low	1
Neoplasms, Brain, Benign	low	1
Neoplasms, Brain, Malignant	low	1
Neoplasms, Brain, Primary	low	1
Neoplasms, Intracranial	low	1
Neuronopathic Gaucher Disease	low	1
Non-Neuronopathic Gaucher Disease	low	1
Pituitary Diencephalic Syndrome	low	1
Primary Brain Neoplasms	low	1
Primary Malignant Brain Neoplasms	low	1
Primary Malignant Brain Tumors	low	1
Streptozocin Diabetes	low	1
Streptozotocin Diabetes	low	1
Subacute Neuronopathic Gaucher Disease	low	1
Type 1 Gaucher Disease	low	1
Type 2 Gaucher Disease	low	1
Type 3 Gaucher Disease	low	1
Vasogenic Brain Edema	low	1
Vasogenic Cerebral Edema	low	1

3,3'-methyliminobis(n-methylpropylamine)

Description

Cross-References

Synonyms (43)

Research

Studies (7)

Study Types

Related Drugs (3)

Related Conditions (125)